LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...

Ocular Therapeutix, Inc. ( OCUL) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT Ocular Therapeutics. Presenting for Ocular today and sitting up on stage with me is Dr.

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Key opportunities in the ranibizumab market include rising demand due to increased prevalence of eye diseases driven by aging ...

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

Incretin-PRINTed rodents, whether maintained on standard chow or a high-fat diet, demonstrated that sustained GLP-1 receptor agonist exposure correlated with favorable PD effects, including reductions ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Growing at a rapid pace, Apex Eyecare is poised to hire a second optometrist and a nurse practitioner in the coming months, ...